4-O-Methylascochlorin inhibits the prolyl hydroxylation of hypoxia-inducible factor-1α, which is attenuated by

Tetsuya Kondo1, Kenji Takeda1, Ryo Muko1

  • 1Department of Applied Biology, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto, 606-8585, Japan.

The Journal of Antibiotics
|February 24, 2019
PubMed

Insights

4-O-Methylascochlorin (MAC) boosts hypoxia-inducible factor (HIF)-1α accumulation in cancer cells by inhibiting prolyl hydroxylation. Ascorbate counteracts this effect, highlighting its role in regulating HIF-1α activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Hypoxia-inducible factor (HIF)-1α is a key regulator of cellular response to hypoxia.
  • 4-O-Methylascochlorin (MAC), a derivative of ascochlorin, has been shown to influence HIF-1α levels.

Purpose of the Study:

  • To investigate the effects of MAC on HIF-1α expression and function in human fibrosarcoma HT-1080 cells.
  • To elucidate the mechanism underlying MAC-mediated HIF-1α accumulation and the role of ascorbate.

Main Methods:

  • Treatment of HT-1080 cells with MAC.
  • Analysis of HIF-1α protein and mRNA levels.
  • Assessment of HIF target gene transcriptional activity.
  • Measurement of HIF-1α prolyl hydroxylation.
  • Evaluation of intracellular ascorbate concentrations.

Main Results:

  • MAC promoted HIF-1α protein accumulation without altering mRNA levels.
  • MAC enhanced the transcriptional activity of HIF target genes.
  • Ascorbate attenuated MAC-induced HIF-1α accumulation and transcriptional activity.
  • MAC inhibited HIF-1α prolyl hydroxylation at proline 564, an effect reversed by ascorbate.
  • MAC caused a slight decrease in intracellular ascorbate.

Conclusions:

  • MAC promotes HIF-1α accumulation by inhibiting its prolyl hydroxylation.
  • Ascorbate plays a role in modulating MAC's effect on HIF-1α prolyl hydroxylation.
  • These findings provide insights into the regulation of HIF-1α by MAC and ascorbate in cancer cells.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.4K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.1K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K